For the latest updates on our ongoing response to COVID-19, please click here.

William A. Lee, PhD

Executive Vice President, Research

William Lee

William Lee is the Executive Vice President of Research at Gilead, overseeing the company's innovative research and preclinical programs across all therapeutic areas. Since joining Gilead in 1991, he has been responsible for the expansion of the company's research programs, leading efforts to advance multiple products from early-stage research into clinical development. His contributions to the discovery of internal drug candidates and evaluation of external compounds have allowed Gilead to bring important new medicines to patients.

Prior to joining Gilead, Bill held positions at Syntex Corp. and California Biotechnology, Inc.

Bill received his bachelor's degree in chemistry from the University of Massachusetts and his PhD in chemistry from the University of California, San Diego. He did postdoctoral work at the Ecole Polytechnique-Federale de Lausanne and the University of California, Santa Barbara.